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Abstract: The kidneys from six immunodeficient mice examined by Cerberus Sciences and 
the Animal Resources Centre, displayed karyomegaly with pale eosinophilic, intranuclear 
inclusions upon histopathological examination. Electron microscopy performed on kidney 
tissue from 5/6 mice demonstrated margination of the chromatin in large nuclei. Laboratory 
tests were used to detect nucleic acid of papillomaviruses, polyomaviruses, circoviruses and 
anelloviruses (4/6 mice), a specific PCR was used to detect murine polyomavirus (1/6), and 
a panel of serological tests was used to detect seroconversion to major murine pathogens 
(1/6). All molecular and serological tests were negative. Immunohistochemistry using 
polyclonal anti-bovine papillomavirus type 1 (BPV-1) L1 antibody, Camvir monoclonal 
anti-papillomavirus antibody (directed against the seven amino acids GFGAMDF found in 
human papillomavirus (HPV) 16 L1 protein), a commercially available mixture of two 
monoclonal antibodies, anti-BPV-1 L1/1H8 + Camvir antibodies, and a monoclonal  
anti-Hsc70 antibody revealed specific, positive staining of murine renal tubular epithelial 
intranuclear inclusions in 6/6 mice using the anti-BPV-1 L1 containing antibodies only. 
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Methyl pyronin green, PAS and Feulgen histochemical reactions revealed that the 
intranuclear inclusions did not consist of RNA, DNA or carbohydrate. An 
immunohistochemical method now exists that can be used to confirm and evaluate suspected 
cases of murine inclusion body nephropathy. 
Keywords: mouse; intranuclear inclusions; renal tubular epithelium; bovine papillomavirus 
type 1 L1 protein
 
1. Introduction
Veterinary pathologists examining mouse kidneys have occasionally noted the presence of large, 
eosinophilic intranuclear inclusions and karyomegaly in the renal tubular epithelium of immunodeficient 
mice [1]. Such observations have been made in kidneys collected from mice submitted for routine colony 
health monitoring, which have not undergone any experimental intervention [2]. When visualised using 
light microscopy, these intranuclear inclusions are morphologically similar to those observed in certain 
DNA virus infections (e.g., adenovirus, cytomegalovirus, and polyomavirus) [3]. Previously performed 
ultrastructural studies have confirmed chromatin margination and the presence of electron lucent 
material within affected nuclei, however no viral particles or other pathogens have yet been identified [2]. 
Serology, microbiology, parasitology, necropsy, histopathology, PCR and immunohistochemistry 
investigations have, to date, all failed to detect a pathogen that might be associated with these murine 
renal intranuclear inclusion bodies, and therefore, the tubular inclusions have so far been considered an 
idiopathic, degenerative lesion [2].  
Here, we report on investigations into the chemical nature of these murine renal tubular intranuclear 
inclusion bodies, and the serendipitous discovery of antibodies that bind to and specifically  
highlight them.  
2. Methods
2.1. Animals and Necropsy 
All details about the mice in this study are included in Table 1. All six mice originated from the 
Animal Resources Centre (ARC) in Perth, Western Australia. Two mice were submitted to Cerberus 
Sciences and four were necropsied by ARC staff, as part of routine health monitoring procedures.  
A complete necropsy was performed on all mice by a veterinary pathologist. The kidneys were 
examined macroscopically and samples of fresh kidney tissue from mice A, C, D, E and F were taken 
for molecular tests, with a small sub-sample fixed in glutaraldehyde for electron microscopy from these 
same mice. Kidneys were collected from all mice and fixed in formalin. The formalin-fixed kidney 
tissues were routinely processed and embedded in paraffin wax, sectioned at 3–4 m and stained with 
hematoxylin and eosin, Feulgen reaction, methyl pyronin green and PAS reaction [4]. Light microscopy 
was performed on these tissues. No experimental procedures were performed on the animals in this study 
and all of the animals were housed and maintained in accordance with the Australian code for the care 
and use of animals for scientific purposes 8th edition (2013) [5].  
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Table 1. Information about the six mice analysed in this study including identification, 
breed, sex and age description. 
Animal  Breed Sex Description Necropsy 
A  
CBySmn.CB17-
Prkdcscid/J
F Ex-breeder Cerberus 
B 
CBySmn.CB17-
Prkdcscid/J 
F Young Cerberus 
C 
NOD.CB17-
Prkdcscid  
F Ex-breeder ARC 
D 
NOD.CB17-
Prkdcscid 
M Ex-breeder ARC 
E 
NOD.CB17-
Prkdcscid 
F Ex-breeder ARC 
F 
B6.129S7-
Rag1tm1M°m/J 
F Ex-breeder ARC 
2.2. Serology 
A whole blood sample was collected by cardiocentesis from mouse B. The blood sample was allowed 
to clot for 30 minutes and was then centrifuged for five minutes at 604.8g and the serum was harvested 
and stored at 20 °C. Serum from mouse B was tested for antibodies against the following murine 
pathogens using the ELISA test: mouse hepatitis virus, mouse minute virus, mouse parvovirus, mouse 
norovirus, rotavirus, Theiler’s murine encephalomyelitis virus, pneumonia virus of mice, Sendai virus, 
Mycoplasma pulmonis, mouse cytomegalovirus, mouse adenovirus 1, reovirus type 3, lymphocytic 
choriomeningitis virus, ectromelia virus, mouse adenovirus 2, murine polyomavirus, Clostridium 
piliforme, hantavirus, Encephalitozoon cuniculi, cilia associated respiratory bacillus, K virus and mouse 
thymic virus. For the ELISA tests, the method of McInnes and co-workers (2011) [6] was used.  
2.3. Electron Microscopy 
Kidney tissue in glutaraldehyde from mice A, C, D, E and F was postfixed in 1 % osmium tetroxides, 
dehydrated and embedded in resin blocks. Sections were stained en-bloc with 1% uranyl acetate and 
ultrathin sections were then stained with Reynold’s lead citrate and examined with a Hitachi H7500 (A) 
or CM 100 BioTwin (C & D) transmission electron microscope (Philips, Eindhoven, The Netherlands). 
2.4. Polymerase Chain Reaction
Total DNA was extracted from the kidneys of mice A, C, D, E, and F with commercially available 
kits (UltraClean® Tissue & Cells DNA Isolation kit (MO BIO Laboratories, Inc, USA); DNEasy Tissue 
and Blood (Qiagen) according to the manufacturers’ instructions. For total DNA extracts from mouse 
A, a PCR reaction mixture contained the following components with final concentration of 20 mmol/L 
Tris-HCl (pH 8.5 at 25 °C), 50 mmol/L KCl, 2 mmol/L MgCl2, 200 μmol/L each dNTP (dATP, dCTP, 
dTTP and dGTP), 0.5 U of Taq polymerase (Fisher Biotec, Australia) and 0.2 μmol/L each primers 
specific for murine polyomavirus VP2 protein-coding region [7] in a final PCR reaction volume of  
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25 μL. The PCR was run on a Peltier thermal cycler (MJ Research, United States) with the following 
temperature program: an initial denaturing step at 94 °C for 5 min, then 40 cycles of 94 °C for 30 s,  
60 °C for 30 s, 72 °C for 30 s. The PCR products were electrophoretically separated in 2% agarose  
E-gels (Invitrogen, Australia) and visualized with UV light [6]. 
A broad-spectrum papillomavirus PCR was performed on DNA extracts from mice C, D, E, and F, 
according to the method described in Forslund et al. (1999) [8]. Multiply primed rolling circle 
amplification was also performed on these same samples, following the method of Rector and co-authors 
(2004, 2005) [3,9]. 
2.5. Immunohistochemistry (IHC) 
The antibodies used for the murine inclusion body IHC were: rabbit polyclonal anti-bovine 
papillomavirus L1 antibody (Dako, Australia) (dilution 1:300), Camvir monoclonal anti-papillomavirus 
antibody (directed against the seven amino acid linear epitope GFGAMDF found in HPV 16 L1  
protein) [10] (dilution 1:300), mixed monoclonal anti-BPV-1 L1/1H8 + Camvir (Abcam) (dilution  
of 1:300) and rabbit monoclonal anti-Hsc70 antibody (EP1531Y) (Novus Biologicals, Australia) 
(dilution 1:400).  
Antigen retrieval was required for the latter three antibodies and was achieved by heating the sections 
in a Tris-EDTA pH 9 buffer using a microwave oven. Endogenous peroxidase activity was quenched 
using a 3% aqueous hydrogen peroxide solution. Prior to the application of the antibodies, all sections 
were pre-treated with 10% normal goat serum which was drained off without washing. The three 
papillomavirus antibodies required an incubation time of 30 minutes while the heat shock cognate 
antibody required 60 minutes. Negative control sections were treated with Tris buffered saline wash 
solution pH 7.8 and isotype control antibodies. Visualisation of all the reactions was achieved with Dako 
Envision+ Dual Link System-HRP (Dako, Australia) for 30 minutes followed by treatment with Dako 
Liquid DAB+ Substrate Chromogen System (Dako, Australia) for three minutes. The sections were then 
counterstained in Harris’s haematoxylin, dehydrated, cleared and cover-slipped. 
3. Results
3.1. Histopathology 
The kidneys from all six mice displayed mild to marked, focal to multifocal karyomegaly of tubular 
epithelial cells. Enlarged nuclei had marginated chromatin and contained pale, eosinophilic, inclusion 
bodies (Figure 1 and 3a). The remaining cells in affected tubules contained abundant pale eosinophilic 
cytoplasm with occasional vacuolation. The majority of intranuclear inclusions were noted in tubular 
epithelium of the renal cortex, however, occasional inclusions were also noted in the tubular epithelium 
of the collecting ducts of the medulla. In addition, mouse A had a lymphoblastic lymphoma of the 
submandibular lymph nodes, spleen, liver, lungs and kidneys. Mouse D had concurrent moderate, 
subacute necrotizing pyelonephritis.  
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Figure 1. Renal cortical tubular intranuclear inclusion bodies (black arrowhead) from mouse 
F stained with haematoxylin and eosin. The black measurement bar represents 100 m. 
3.2. Electron Microscopy 
The renal tubular epithelium of the mice examined by electron microscopy displayed multiple, 
enlarged nuclei within tubular epithelial cells. Chromatin was displaced peripherally within affected 
nuclei, around abundant electron lucent material (Figure 2). No recognisable viral particles were 
observed within the enlarged tubular epithelial nuclei, however, at higher magnifications (up to × 
100,000) the intranuclear material showed both a granular and fibrillar composition.  
3.3. Laboratory Tests 
The kidneys from mouse A were negative for murine polyomavirus by PCR. Mice C, D, E and F were 
negative for papillomaviruses by PCR, and negative for small circular DNA genomes (i.e., 
papillomaviruses, polyomaviruses, circoviruses, anelloviruses) by multiply primed rolling circle 
amplification. Serology for mouse B was negative for all organisms tested. 
Vet. Sci. 2015, 2 89
 
 
Figure 2. Chromatin displaced peripherally within affected nuclei, around abundant electron 
lucent material. Mouse A (lead citrate and uranyl acetate).  
3.4. Histochemistry and Immunohistochemistry
Histochemical stains demonstrated that the inclusion bodies in all six mice did not consist of DNA, 
RNA or carbohydrate (Table 2, Figure 3b,c,d). Immunostaining with Hsc70 showed a mixture of 
cytoplasmic and nuclear staining in kidney cells, but this was not always related to the presence of the 
intranuclear inclusions (Table 2, Figure 3e). The anti-papillomavirus antibodies (polyclonal and 
monoclonal) that included reactivity against bovine papillomavirus type 1 L1 protein, specifically, 
consistently and strongly produced positive immunostaining of the intranuclear inclusions (Table 2, 
Figure 3f,g). In contrast, the Camvir monoclonal anti-papillomavirus antibody produced no 
immunostaining of murine kidney tissues (Table 2, Figure 3h).  
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Figure 3. (a) Renal cortical tubular intranuclear inclusion bodies from mouse F stained with 
haematoxylin and eosin (b) Feulgen reaction, (c) Methyl Green Pyronin, (d) Periodic Acid 
Schiff’s reaction, (e) anti-Hsc70 monoclonal antibody, (f) polyclonal rabbit anti bovine 
papillomavirus type 1 L1 protein antibody, (g) a mixture of Camvir + monoclonal mouse 
anti bovine papillomavirus type 1 L1 protein antibody (the latter component’s epitope 
binding specificity is not known), (h) Camvir monoclonal antibody. The black arrows 
demonstrate the findings in the intranuclear inclusions. 
Table 2. The results of the histochemical and immunohistochemical staining used in  
this study.  
Animal  A B C D E F 
H&E + + + + + + 
Mixed monoclonal anti-BPV-1 
L1/1H8 + Camvir 
+ + + + + + 
Rabbit polyclonal anti-bovine 
papillomavirus L1 antibody 
+ + + + + + 
Camvir monoclonal anti-
papillomavirus antibody 
– – – – – – 
Rabbit monoclonal anti-Hsc70 cyto > nuc cyto > nuc weak + weak + weak + weak + 
PAS – – – – – – 
Feulgen – – – – – – 
Methyl Green Pyronin – – – – – – 
4. Discussion 
The histochemistry results indicate the inclusion bodies are not composed of nucleic acid or 
carbohydrate, leaving protein as the most likely major chemical constituent. Immunohistochemistry 
experiments for detecting Hsc70 showed that the intranuclear inclusions in the renal tubular cells in the 
immunodeficient mice were typically associated with heat shock cognate 70. Heat shock cognate 71 kDa 
protein (also known as Hsc70, Hsp73 and heat shock 70 kDa protein 8) is a molecular chaperone that 
protects cells from the damage caused by physical and chemical hazards [11]. Hsc70 is normally found 
predominantly within the cellular cytoplasm, but may be recruited to the nuclear compartment following 
non-specific insults to the nucleus [12]. In complex with a range of other cellular proteins, Hsc70 
chaperones the repair process within damaged nuclei [12]. If the nuclear damage can be ameliorated, 
Hsc70 will exit the nucleus and re-enter the cytoplasm [12]. The detection of Hsc70 within nuclei 
affected by the murine renal tubular intranuclear inclusions indicates that affected nuclei have been 
damaged, but does not implicate any particular cause of the insult. The presence of chromatin 
margination observed by light and electron microscopy also supports the hypothesis that affected cells 
have incurred some insult, as it is recognised as an early change occurring in the nucleus following 
irreversible injury, which ultimately leads to cell death [13]. While anti-Hsc70 antibodies appeared to 
bind to the intranuclear inclusion bodies themselves, it seems that Hsc70 is not the sole constituent of 
these inclusion bodies.  
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Immunohistochemistry experiments using three different antibody preparations for detecting 
papillomavirus L1 protein revealed that no immunostaining was demonstrable using Camvir, which 
recognises the seven amino acid long linear epitope GFGAMDF of human papillomavirus (HPV) type 
16 L1. Conversely, both polyclonal and monoclonal antibodies for bovine papillomavirus (BPV) type 1 
L1 showed strong, specific immunostaining of the intranuclear inclusion bodies. Molecular tests and 
ultrastructural investigations, in this report and in previous studies, have consistently failed to 
demonstrate the presence of any virus within affected kidney tissue [2]. The immunohistochemistry 
results using anti-BPV1 L1 antibodies provide evidence that there is an epitope, antigenically similar 
enough to BPV1 L1 to permit antibody binding, present within the intranuclear inclusion bodies.  
The monoclonal anti-BPV-1 L1/1H8 antibody found in the mixture with Camvir (Abcam) has not yet 
had its binding specificity determined. Therefore, it cannot be concluded with any certainty as to which 
linear or conformational epitope this antibody has bound within the intranuclear inclusion body. The 
binding specificities of the polyclonal against BPV1 L1 have been described [14], however this product 
is no longer commercially available. 
There is some published evidence of extra-epithelial localization of human papillomaviruses. 
Bodaghi et al. (2005) [15] provided some experimental evidence to support their contention that human 
papillomaviruses (HPV) may be spread through blood. Subsequently, Chen et al. (2009) [16] reported 
successfully detecting HPV (human papillomavirus) DNA using PCR on peripheral blood of Australian 
male blood donors, although they suggested the human papillomaviruses they detected were most likely 
attached to the surface of blood cells, rather than productively infecting the blood cells.  
More controversially, Roperto et al. (2012) [17] claimed to have detected productive BPV2 (bovine 
papillomavirus) infection within the placentas of cows with urinary bladder tumours and in an earlier 
work, Roperto et al. (2011) [18] claimed there was productive BPV2 (bovine papillomavirus) infection 
of peripheral blood lymphocytes in a cow with papillary carcinoma of the urinary bladder. Based on 
these previous reports, it is conceivable that a papillomavirus or related virus may indeed be involved in 
the pathogenesis of murine renal tubular intranuclear inclusions, although this should be considered an 
unlikely possibility at this stage.  
Rodent species with described papillomaviruses include Erethizon dorsatum [3], Mastomys
coucha [19], Mesocricetus auratus [20,21], Micromys minutus [22,23], Mastomys natalensis [24],  
Mus musculus [20,25–27] It remains unlikely that the inclusions were caused by a murine papillomavirus 
as no other evidence of a murine papillomavirus infection was found. 
An alternate hypothesis is that an unknown endogenous murine protein, when concentrated within 
the nucleus, provides linear or conformational epitopes that antigenically resemble part of the BPV1 L1 
protein closely enough, that the anti-BPV1 L1 antibodies used in these experiments cross-react to 
produce strong, specific positive immunostaining. 
Previous reports have indicated that the inclusions have been noted in immunodeficient mice [2,1,28,29]. 
Here, the six mice were all severely immunodeficient (CBySmn.CB17-Prkdcscid/J, NOD.CB17-Prkdcscid/J 
and B6.129S7-Rag1tm1Mom/J), but the immunodeficiencies of the CBySmn.CB17-Prkdcscid/J and 
B6.129S7-Rag1tm1Mom/J mice have been produced through different genetic lesions. This indicates that 
the propensity to develop murine renal tubular intranuclear inclusion bodies appears to be associated 
with severe immunodeficiency brought about by impaired adaptive immune system function, and is not 
a direct product of one particular genetic lesion. It is interesting to note that in the present study 5/6 mice 
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were female and 7/8 mice described by Baze and coworkers [2], were also female. The reasons for this 
apparent sex bias are unclear.
Known nephrotoxins include heavy metals, ochratoxin A [30], aminoglycoside antibiotics, 
hydrocarbons, non-steroidal anti-inflammatory drugs, some anesthetic agents, oxalates and radiographic 
contrast media [31]. In our study, it seems unlikely that these agents were involved in the pathogenesis 
of the inclusion bodies, as the mice had no known exposure to them, the mice were kept in specific 
pathogen free conditions and most of these agents are not known for producing intranuclear inclusion 
bodies. Lead exposure, on the other hand, is known to produce intranuclear and intracytoplasmic 
inclusions in the proximal convoluted tubules of many animal species [32], however, the ultrastructural 
investigations performed in this study showed that affected nuclei were filled with an electron lucent 
material, and this is inconsistent with lead inclusions that have an electron dense central core surrounded 
by a zone of fibrillar structures. Nonetheless, the possibility remains that an unknown environmental 
insult may have been associated with the formation of renal tubular intranuclear inclusions in these mice. 
5. Conclusions 
In the absence of a more definitive understanding of their composition and pathogenesis, these 
perplexing inclusions should, for the time being, be considered part of the normal background pathology 
of immunodeficient mice. Regardless of the precise identity of the binding site for the immunohistochemical 
reaction, an immunohistochemical method now exists that can be used to confirm and evaluate the 
histological severity and distribution of suspected cases of murine inclusion body nephropathy.  
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